Skip to main content
Top

Cancer Causes & Control

Issue 3/2020

Content (8 Articles)

Prostate Cancer Original Paper

Patient- and area-level predictors of prostate cancer among South Carolina veterans: a spatial analysis

Peter Georgantopoulos, Jan M. Eberth, Bo Cai, Christopher Emrich, Gowtham Rao, Charles L. Bennett, Kathlyn S. Haddock, James R. Hébert

Breast Cancer Original Paper

Integrating access to care and tumor patterns by race and age in the Carolina Breast Cancer Study, 2008–2013

Marc A. Emerson, Yvonne M. Golightly, Xianming Tan, Allison E. Aiello, Katherine E. Reeder-Hayes, Andrew F. Olshan, H. Shelton Earp, Melissa A. Troester

Colorectal Cancer Original Paper

Rural–urban disparities in colorectal cancer survival and risk among men in Utah: a statewide population-based study

Charles R. Rogers, Brenna E. Blackburn, Matthew Huntington, Karen Curtin, Roland J. Thorpe Jr., Kerry Rowe, John Snyder, Vikrant Deshmukh, Michael Newman, Alison Fraser, Ken Smith, Mia Hashibe

NSCLC Original Paper

Comorbidity and stage at diagnosis among lung cancer patients in the US military health system

Jie Lin, Katherine A. McGlynn, Joel A. Nations, Craig D. Shriver, Kangmin Zhu

Nephrectomy Original Paper

Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities

Stefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, Sophie Knipper, Angela Pecoraro, Sebastiano Nazzani, Zhe Tian, Gennaro Musi, Emanuele Montanari, Shahrokh F. Shariat, Fred Saad, Alberto Briganti, Ottavio de Cobelli, Pierre I. Karakiewicz

Open Access Prostate Cancer Original Paper

Allergy, asthma, and the risk of breast and prostate cancer: a Mendelian randomization study

Xia Jiang, Niki L. Dimou, Zhaozhong Zhu, Carolina Bonilla, Sarah J. Lewis, Sara Lindström, Peter Kraft, Konstantinos K. Tsilidis, Richard M. Martin

Prostate Cancer Original Paper

The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages

Sophie Knipper, Angela Pecoraro, Carlotta Palumbo, Giuseppe Rosiello, Stefano Luzzago, Marina Deuker, Zhe Tian, Shahrokh F. Shariat, Fred Saad, Derya Tilki, Markus Graefen, Pierre I. Karakiewicz

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine